About This Fund
Gyrus Capital Fund II is a private equity fund based in Geneva, Switzerland. The target investments of Gyrus Capital Fund II are in the healthcare and sustainability sectors. They focus on businesses operating in these sectors, particularly those involved in complex transactions such as corporate carve-outs and entrepreneur successions in the €50 to €500 million range. The fund has already completed its first investment in LRE Medical, a leading CDMO specialized in point-of-care diagnostic and life science devices. Gyrus has completed seven platform investments to date, including four carve-outs and three founder partnerships. The fund aims to support management to drive change and unlock value in these businesses. Gyrus has a focus on long-term growth and out-performance for its investors through its investments in the healthcare and sustainability sectors, leveraging its sector focus and deep corporate carve-out experience. The firm has a team of experienced operating partners and industry experts to support its active investment and value-creation approach in close partnership with entrepreneurs and managers. Fund II consists of the Principal Fund and an open-ended Co-investment vehicle, allowing the Firm to make larger investments.